Actuate Therapeutics Inc (ACTU) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Actuate Therapeutics Inc and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PTN
Palatin Technologies, Inc.
$9.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ACTU vs PTN
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)PTN -87.4% (-64.4%/yr)PTN compounded faster over this window
ACTU PTN
ACTU vs PTN: by the numbers
- •ACTU is the larger company ($19M vs $17M market cap).
- •Both run net losses; ACTU's is the smaller (0.00% vs -63.54% net margin).
Metrics side by side
Valuation
| Metric | ACTU | PTN |
|---|---|---|
| P/S ratio | N/A | 1.27 |
| P/B ratio | 19.63 | 2.50 |
Profitability
| Metric | ACTU | PTN |
|---|---|---|
| Gross margin | 0.00% | 99.63% |
| Operating margin | 0.00% | -65.74% |
| Net margin | 0.00% | -63.54% |
| ROE | -2067.81% | -125.30% |
| ROIC | -1489.99% | -125.44% |
Growth (annualized)
| Metric | ACTU | PTN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -55.41% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.